ResearcherGerman Cancer Research CenterNo recent work listed
Thomas Brabletz
Matched on ORCID iD 0000-0003-2983-9048; OpenAlex author ID A5076332139. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 5
- Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. First author DOI 10.3389/fcell.2021.753456↗
- ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancrea… Co-author DOI 10.1053/j.gastro.2019.10.038↗
- Upholding a role for EMT in pancreatic cancer metastasis. First author DOI 10.1038/nature22963↗
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Last author DOI 10.1038/ncb3513↗
- Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jgh.12752↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marc P. Stemmler · 3 shared papers, 2017–2021 · strength 0.34
- Paper Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. DOI 10.3389/fcell.2021.753456↗
- Paper ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the… DOI 10.1053/j.gastro.2019.10.038↗
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513↗
- Ruthger van Roey · 1 shared paper, 2021 · strength 0.19
- Isabell Armstark · 1 shared paper, 2021 · strength 0.19
- Yu‐Qing Zhang · 1 shared paper, 2020 · strength 0.09
- Min Li · 1 shared paper, 2020 · strength 0.09
- Xiaobo Cui · 1 shared paper, 2020 · strength 0.09
- Mingyang Liu · 1 shared paper, 2020 · strength 0.09
- Barish H. Edil · 1 shared paper, 2020 · strength 0.09
- Zhijun Zhou · 1 shared paper, 2020 · strength 0.09
- Jingxuan Yang · 1 shared paper, 2020 · strength 0.09
- Courtney W. Houchen · 1 shared paper, 2020 · strength 0.09
- Hanxiang Zhan · 1 shared paper, 2020 · strength 0.09
- Martín E. Fernández-Zapico · 1 shared paper, 2020 · strength 0.09
- Robert A. Weinberg · 1 shared paper, 2017 · strength 0.08
- Nicole M. Aiello · 1 shared paper, 2017 · strength 0.08
- Ben Z. Stanger · 1 shared paper, 2017 · strength 0.08
- Angela M. Krebs · 1 shared paper, 2017 · strength 0.06
- Melanie Boerries · 1 shared paper, 2017 · strength 0.06
- Wilfried Reichardt · 1 shared paper, 2017 · strength 0.06
- Christian P. Pilarsky · 1 shared paper, 2017 · strength 0.06
- Sylvia Timme · 1 shared paper, 2015 · strength 0.05
- Ilona Kohler · 1 shared paper, 2015 · strength 0.05
- Dirk Bausch · 1 shared paper, 2015 · strength 0.05
- Tobias Keck · 1 shared paper, 2015 · strength 0.05
- Ulrich Friedrich Wellner · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.